Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Non-Customized |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Febuxostat is an anti-gout medicine mainly used for the long-term treatment of hyperuricemia in gout patients.
It is a xanthine oxidase inhibitor, which reduces serum uric acid concentration by inhibiting uric acid synthesis and thus exerts its medicinal effects.
Items | Specifications |
---|---|
Name | Febuxostat |
CAS No. | 144060-53-7 |
Solubility | Freely soluble in N,N-dimethyl formamide, sparingly soluble in ethanol or trichloromethane, practically insoluble in water. |
Identification | The retention time of the major peak of the sample solution corresponds to that of the standard solution, as obtained in the assay. |
Residue on ignition | ≤0.1% |
Molecular Weight | 316.381 |
Einecs | 682-158-6 |
Character | Off-white crystalline powder, odourless |
Assay | 99.6% |
Febuxostat
5-Thiazolecarboxylic acid,2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-;2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid;TEI 6720;TMX 67;2-(3-Cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid;Febuxostat;FBX;Uloric;Feburic;Febugood;Febutaz;Zurig;2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid;2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid;Adenuric
144060-53-7
C16H16N2O3S
InChIKey=BQSJTQLCZDPROO-UHFFFAOYSA-N
316.37500
316.37
101V0R1N2E
758874
DTXSID8048650
C65629
M04AA03|M - Musculo-skeletal system